The application of chest wall perforator flaps in total breast reconstruction after mastectomy for breast cancer: A case report
Breast Global Journal · 2023
DOI: 10.4103/bgj.bgj_14_23 ↗Kurz gefasst
Fallbericht in der Zeitschrift Breast Global Journal, 2023. Verfasst von Dimitrios Kokkonis und 1 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
A bstract Chest wall perforator flaps (CWPFs) have become a useful tool in oncoplastic surgery in recent years, and they can facilitate breast-conserving surgery for women who would otherwise be candidates for mastectomy. Patients with excess skin and fat in the lateral chest wall can be suitable for this technique. So far, it was believed that these local flaps cannot provide adequate volume for total breast reconstruction. Thus, there is a paucity of data on the subject, except for very few small case series worldwide. Here, we present a case report of a female breast cancer patient who underwent immediate total breast reconstruction after mastectomy, using two stacked perforator flaps from the lateral chest wall and the upper abdomen. This case report shows that CWPF can be a new alternative to other methods of breast reconstruction, such as implants and free or pedicled musculocutaneous flaps.
Zitieren
APA
Kokkonis, D., & Zambia, K. (2023). The application of chest wall perforator flaps in total breast reconstruction after mastectomy for breast cancer: A case report. Breast Global Journal. https://doi.org/10.4103/bgj.bgj_14_23
Vancouver
Kokkonis D, Zambia K. The application of chest wall perforator flaps in total breast reconstruction after mastectomy for breast cancer: A case report. Breast Global Journal. 2023. doi:10.4103/bgj.bgj_14_23
BibTeX
@article{Kokkonis2023,
author = {Kokkonis, Dimitrios and Zambia, Koukouritaki},
title = {The application of chest wall perforator flaps in total breast reconstruction after mastectomy for breast cancer: A case report},
journal = {Breast Global Journal},
year = {2023},
doi = {10.4103/bgj.bgj_14_23}
}
EUVIMED